Evidence map›Paper›PMID 23006841›Full record

ArticleMolecular pain2012

The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain.

Shivani Ruparel, Dustin Green, Paul Chen, Kenneth M Hargreaves

Abstract read
In one paragraph

Article in Molecular pain, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Oxidized Lipids in Persistent Pain States.Frontiers in pharmacology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shivani RuparelDepartment of Endodontics, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Dustin Green
Paul Chen
Kenneth M Hargreaves

Funding

Institutional Research Training GrantT32DE014318 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Kenneth M Hargreaves · 2002 to 2026
$12.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR000149 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2012 to 2013
$6.8M
Role of Oxidized Linoleic Acid Metabolites in PainR01NS072890 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HARGREAVES, KENNETH M · 2010 to 2014
$1.8M
Cannabinoid Modulation of Capsaicin-Sensitive NociceptorsR01DA019585 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HARGREAVES, KENNETH M · 2006 to 2010
$1.4M
The Role of the OLAM System in Burn PainF31NS082019 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GREEN, DUSTIN PEPPER · 2013 to 2014
$53k
NCATS NIH HHS UL1TR000149NIDA NIH HHS R01DA019585NINDS NIH HHS F31 NS082019NINDS NIH HHS R01 NS072890NINDS NIH HHS R01NS72890
6 · The paper itself

Abstract

backgroundOxidized linoleic acid metabolites (OLAMs) are a class of endogenous agonists to the transient receptor potential V1 (TRPV1) receptor. Although TRPV1 mediates inflammatory heat hyperalgesia, it is not known if the OLAMs contribute to the peripheral activation of this receptor during tissue inflammation. In the present study, we evaluated whether the OLAM system is activated during inflammation and whether cytochrome P450 enzymes mediate OLAM contributions to heat hyperalgesia using the complete Freund's adjuvant (CFA) model of inflammation.

resultsOur results demonstrate that the intraplantar (ipl) injection of anti-OLAM antibodies significantly reversed CFA-induced heat hyperalgesia. Moreover, application of lipid extracts from inflamed rat skin to cultured sensory neurons triggered a significant release of iCGRP that is blocked by co-treatment with I-RTX, a TRPV1 antagonist. To determine the role of CYP enzymes in mediating OLAM effects, we used a broad spectrum CYP inhibitor, ketoconazole. Pretreatment with ketoconazole inhibited the release of TRPV1 agonists in lipid extracts from inflamed skin and significantly reversed CFA-induced heat hyperalgesia by a peripheral mechanism of action. Moreover, the ipl injection of linoleic acid to rats 24 hr after CFA evoked spontaneous nocifensive behaviors that were significantly reduced by capsazepine, by knockout of the TRPV1 gene, or by pretreatment with either anti-OLAM antibodies or ketoconazole.

conclusionsTaken together, our data suggests that OLAMs contribute to inflammatory nociception in the periphery and that cytochrome P450 enzymes play a crucial role in mediating OLAM contributions to inflammatory heat hyperalgesia.

Indexed as

Cytochrome P-450 Enzyme InhibitorsAnimalsAntibodiesBehavior, AnimalCytochrome P-450 Enzyme SystemEnzyme InhibitorsFreund's AdjuvantHot TemperatureHyperalgesiaInflammationKetoconazoleLinoleic AcidLinoleic AcidsLinoleic Acids, ConjugatedMiceMice, Inbred C57BL13-hydroxy-9,11-octadecadienoic acid9-hydroxy-10,12-octadecadienoic acidAntibodiesCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemEnzyme InhibitorsFreund's AdjuvantKetoconazoleLinoleic AcidLinoleic AcidsLinoleic Acids, ConjugatedTrpv1 protein, ratTRPV Cation Channels

Identifiers

PMID23006841
PMCPMC3488501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.